$1.39-5.44%
2026-10-06 close · prelimLoading chart…
Today's signals · No active technical signal.
Signal details →RenovoRx last closed at $1.39 (-5.44%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -5.7×. Its overall grade ranks 290 of 741 stocks in Healthcare.
About this company
RenovoRx last closed at $1.39 (-5.44%) on 2026-10-06. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B+ · 290/741
Valuation grade B-
Related stocks
- MerckCustomer
주요 병용 항암제 협력/적용 가능 고객
- PfizerCustomer
항암제 병용 치료 파트너 후보
- Bristol Myers SquibbCustomer
항암제 병용 치료 확장 관련 고객
About RenovoRx
- What technical signals does RenovoRx (RNXT) have?
- RenovoRx current technical signals: no active technical signal.
- Is RenovoRx a cup-and-handle pattern?
- No. RenovoRx has no valid Cup signal right now.
- What published figures are available for RenovoRx?
- Market cap: $50.94M. Trailing 12 months PER: -5.7×. Latest quarter PBR: 7.74×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about RenovoRx, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy